240 related articles for article (PubMed ID: 7072727)
1. Current FDA directives for promoting public health.
Hayes AH
Am J Hosp Pharm; 1982 Mar; 39(3):427-31. PubMed ID: 7072727
[TBL] [Abstract][Full Text] [Related]
2. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
3. The role of the FDA in the effort against AIDS.
Young FE
Public Health Rep; 1988; 103(3):242-5. PubMed ID: 3131814
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical provisions of the FDA Modernization Act of 1997: one year and counting.
Binder GM
Curr Opin Biotechnol; 1999 Jun; 10(3):303-6. PubMed ID: 10361077
[TBL] [Abstract][Full Text] [Related]
5. Institutional pharmacists' guide to complying with PPI regulations.
Greenberg RB
Am J Hosp Pharm; 1980 Dec; 37(12):1656-9. PubMed ID: 7446540
[TBL] [Abstract][Full Text] [Related]
6. The FDA and drug safety: a proposal for sweeping changes.
Furberg CD; Levin AA; Gross PA; Shapiro RS; Strom BL
Arch Intern Med; 2006 Oct; 166(18):1938-42. PubMed ID: 17030825
[TBL] [Abstract][Full Text] [Related]
7. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
Watson KT; Barash PG
Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
[TBL] [Abstract][Full Text] [Related]
8. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121
[TBL] [Abstract][Full Text] [Related]
9. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
[TBL] [Abstract][Full Text] [Related]
10. The FDA at work: cutting-edge science promoting public health.
Hilts PJ
FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824
[No Abstract] [Full Text] [Related]
11. New drug and antibiotic regulations--FDA. Proposed rule.
Fed Regist; 1982 Oct; 47(202):46622-66. PubMed ID: 10262075
[TBL] [Abstract][Full Text] [Related]
12. Sources of drug information: FDA-approved labeling and other official FDA sources.
Lindstrom JA
Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349
[TBL] [Abstract][Full Text] [Related]
13. The importance of GRAS to the functional food and nutraceutical industries.
Burdock GA; Carabin IG; Griffiths JC
Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
[TBL] [Abstract][Full Text] [Related]
14. FDA board investigates Depo-Provera safety.
Contracept Technol Update; 1983 Mar; 4(3):25-7. PubMed ID: 12266161
[TBL] [Abstract][Full Text] [Related]
15. The Kennedy version of the Drug Regulation Reform Act.
Greenberg RB
Am J Hosp Pharm; 1979 Sep; 36(9):1230-4. PubMed ID: 386790
[TBL] [Abstract][Full Text] [Related]
16. The Prescription Drug Marketing Act of 1987.
Greenberg RB
Am J Hosp Pharm; 1988 Oct; 45(10):2118-26. PubMed ID: 3228083
[TBL] [Abstract][Full Text] [Related]
17. FDA hearing highlights opposition to dietary supplement practices; written comments due August 20. Food and Drug Administration.
James JS
AIDS Treat News; 1999 Aug; (No 324):3-4. PubMed ID: 11366575
[TBL] [Abstract][Full Text] [Related]
18. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
[TBL] [Abstract][Full Text] [Related]
19. Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice.
Fed Regist; 1982 Sep; 47(173):39249-50. PubMed ID: 10258155
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical trademarks: navigating through the FDA's pilot program.
Ferrer E
Drug News Perspect; 2010 Jun; 23(5):333-6. PubMed ID: 20603657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
